Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76001 - 76025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ouabain	Approved	CCNA2	890	downregulated	Ouabain results in decreased expression of CCNA2 mRNA	4q27	A24338
Ouabain	Approved	CDK2	1017	downregulated	Ouabain results in decreased expression of CDK2 mRNA	12q13.2	A24337 A24338
Ouabain	Approved	CDKN1A	1026	downregulated	Ouabain results in decreased expression of CDKN1A mRNA	6p21.2	A24338
Ouabain	Approved	CDKN1A	1026	upregulated	Ouabain results in increased expression of CDKN1A mRNA	6p21.2	A24337
Ouabain	Approved	DDOST	1650	downregulated	Ouabain results in decreased expression of DDOST mRNA	1p36.12	A24335
Ouabain	Approved	DRD1	1812	downregulated	Ouabain results in decreased expression of DRD1 mRNA	5q35.2	A24339
Ouabain	Approved	ERCC4	2072	downregulated	Ouabain results in decreased expression of ERCC4 mRNA	16p13.12	A21830
Ouabain	Approved	FANCD2	2177	downregulated	Ouabain results in decreased expression of FANCD2 mRNA	3p25.3	A21830
Ouabain	Approved	FANCF	2188	downregulated	Ouabain results in decreased expression of FANCF mRNA	11p14.3	A21830
Ouabain	Approved	FANCI	55215	downregulated	Ouabain results in decreased expression of FANCI mRNA	15q26.1	A21830
Ouabain	Approved	FARS2	10667	upregulated	Ouabain results in increased expression of FARS2 mRNA	6p25.1	A24335
Ouabain	Approved	FKBP7	51661	upregulated	Ouabain results in increased expression of FKBP7 mRNA	2q31.2	A24335
Ouabain	Approved	GLRB	2743	upregulated	Ouabain results in increased expression of GLRB mRNA	4q32.1	A24335
Ouabain	Approved	GTPBP6	8225	upregulated	Ouabain results in increased expression of GTPBP6 mRNA	Xp22.33 and Yp11.32	A24335
Ouabain	Approved	HNRNPDL	9987	downregulated	Ouabain results in decreased expression of HNRNPDL mRNA	4q21.22	A24335
Ouabain	Approved	IL2RA	3559	downregulated	Ouabain results in decreased expression of IL2RA mRNA	10p15.1	A24340
Ouabain	Approved	KCND2	3751	upregulated	Ouabain results in increased expression of KCND2 mRNA	7q31.31	A24335
Ouabain	Approved	MYC	4609	downregulated	Ouabain results in decreased expression of MYC mRNA	8q24.21	A24338
Ouabain	Approved	NPC2	10577	downregulated	Ouabain results in decreased expression of NPC2 mRNA	14q24.3	A24335
Ouabain	Approved	PCNA	5111	downregulated	Ouabain results in decreased expression of PCNA mRNA	20p12.3	A24337 A24338
Ouabain	Approved	PPT2	9374	downregulated	Ouabain results in decreased expression of PPT2 mRNA	6p21.32	A24335
Ouabain	Approved	PTPN2	5771	downregulated	Ouabain results in decreased expression of PTPN2 mRNA	18p11.21	A24335
Ouabain	Approved	RPGRIP1L	23322	downregulated	Ouabain results in decreased expression of RPGRIP1L mRNA	16q12.2	A24335
Ouabain	Approved	ZFHX3	463	downregulated	Ouabain results in decreased expression of ZFHX3 mRNA	16q22.2-q22.3	A24335
Sucrose	Approved Investigational	FGF2	2247	upregulated	Sucrose results in increased expression of FGF2 mRNA	4q28.1	A21896

Displaying entries 76001 - 76025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability